CD274 and gastric cancer: Immune checkpoint inhibitors enhance the prognosis of GC of patients, among which PD-L1/PD-1 arresters have excellent anti-tumor immunological effectiveness (207) .This also brings a new dawn for exploring the mechanism of cuproptosis in the immunotherapy of gastric malignant tumor microenvironment.